What is the current valuation of the genetic counseling market in 2024?

The overall market valuation was $34.35 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected valuation for 2035 is $152.36 Million. Read More

What is the expected CAGR for the genetic counseling market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 14.5%. Read More

Who are the key players in the genetic counseling market?

Key players in the market include Myriad Genetics, Invitae Corporation, Ambry Genetics, GeneDx, Fulgent Genetics, 23andMe, Color Genomics, and Natera. Read More

What are the different counseling approaches in the market?

The counseling approaches include Integrated, Independent, and Discretionary Genetic Counseling, with valuations ranging from $9.35 Million to $65 Million. Read More

What business models are represented by key players in the market?

The business models include Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, and Clinical Genetic Testing Companies, with valuations from $10 Million to $55 Million. Read More

What are the primary channels for genetic counseling services?

The primary channels include Providers and Self-Referred Individuals, with valuations between $14.35 Million and $85 Million. Read More

What types of services are offered in the genetic counseling market?

Types of services include Risk Assessment, Pharmacogenomics, and Other Genetic Pediatric Care Counseling Services, with valuations from $10 Million to $55 Million. Read More

What applications are driving the genetic counseling market?

Applications include Proactive Risk Assessment, GC For Intent-to-Treat Patients, and Prenatal and Preconception Care, with valuations from $4.35 Million to $60 Million. Read More

What target population segments are being served in the genetic counseling market?

The target population segments include the General Population and Patient Population, with valuations from $10.35 Million to $107 Million. Read More

GCC Genetic Counseling Market

ID: MRFR/LS/50614-HCR

200 Pages

Vikita Thakur

Last Updated: April 06, 2026

GCC Genetic Counseling Market Research Report: By Counseling Approach (Integrated, Independent, Discretionary Genetic Counseling), By Key Players Business Model (Core Genetic Counseling Companies, Direct-to-Consumer Genetic Testing Companies, Clinical Genetic Testing Companies), By Channel (Providers, Self-Referred Individuals), By Type of Service (Risk Assessment, Pharmacogenomics, Other Genetic Pediatric Care Counseling Services), By Application (Proactive Risk Assessment, GC For Intent-to-Treat Patients (ITT), Prenatal and Preconception Care, Other), By Target Population Segment (General Population, Patient Population) andBy Level of Service (Pre-counseling Support, Post Counseling Support) - Growth & Industry Forecast 2025 To 2035

GCC Genetic Counseling Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Counseling Approach (USD Million)
  1. 4.1.1 Integrated
  2. 4.1.2 Independent
  3. 4.1.3 Discretionary Genetic Counseling
2. 4.2 Healthcare, BY Key Players Business Model (USD Million)
  1. 4.2.1 Core Genetic Counseling Companies
  2. 4.2.2 Direct-to-Consumer Genetic Testing Companies
  3. 4.2.3 Clinical Genetic Testing Companies
3. 4.3 Healthcare, BY Channel (USD Million)
  1. 4.3.1 Providers
  2. 4.3.2 Self-Referred Individuals
4. 4.4 Healthcare, BY Type of Service (USD Million)
  1. 4.4.1 Risk Assessment
  2. 4.4.2 Pharmacogenomics
  3. 4.4.3 Other Genetic Pediatric Care Counseling Services
5. 4.5 Healthcare, BY Application (USD Million)
  1. 4.5.1 Proactive Risk Assessment
  2. 4.5.2 GC For Intent-to-Treat Patients (ITT)
  3. 4.5.3 Prenatal and Preconception Care
  4. 4.5.4 Others
6. 4.6 Healthcare, BY Target Population Segment (USD Million)
  1. 4.6.1 General Population
  2. 4.6.2 Patient Population
7. 4.7 Healthcare, BY Level of Service (USD Million)
  1. 4.7.1 Pre-counseling Support
  2. 4.7.2 Post Counseling Support
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Myriad Genetics (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Invitae Corporation (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Ambry Genetics (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GeneDx (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Fulgent Genetics (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 23andMe (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Color Genomics (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Natera (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 GCC MARKET ANALYSIS BY COUNSELING APPROACH
3. 6.3 GCC MARKET ANALYSIS BY KEY PLAYERS BUSINESS MODEL
4. 6.4 GCC MARKET ANALYSIS BY CHANNEL
5. 6.5 GCC MARKET ANALYSIS BY TYPE OF SERVICE
6. 6.6 GCC MARKET ANALYSIS BY APPLICATION
7. 6.7 GCC MARKET ANALYSIS BY TARGET POPULATION SEGMENT
8. 6.8 GCC MARKET ANALYSIS BY LEVEL OF SERVICE
9. 6.9 KEY BUYING CRITERIA OF HEALTHCARE
10. 6.10 RESEARCH PROCESS OF MRFR
11. 6.11 DRO ANALYSIS OF HEALTHCARE
12. 6.12 DRIVERS IMPACT ANALYSIS: HEALTHCARE
13. 6.13 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
14. 6.14 SUPPLY / VALUE CHAIN: HEALTHCARE
15. 6.15 HEALTHCARE, BY COUNSELING APPROACH, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY COUNSELING APPROACH, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY KEY PLAYERS BUSINESS MODEL, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY KEY PLAYERS BUSINESS MODEL, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY CHANNEL, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY CHANNEL, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY TYPE OF SERVICE, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY TYPE OF SERVICE, 2024 TO 2035 (USD Million)
23. 6.23 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
24. 6.24 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
25. 6.25 HEALTHCARE, BY TARGET POPULATION SEGMENT, 2024 (% SHARE)
26. 6.26 HEALTHCARE, BY TARGET POPULATION SEGMENT, 2024 TO 2035 (USD Million)
27. 6.27 HEALTHCARE, BY LEVEL OF SERVICE, 2024 (% SHARE)
28. 6.28 HEALTHCARE, BY LEVEL OF SERVICE, 2024 TO 2035 (USD Million)
29. 6.29 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 GCC MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY COUNSELING APPROACH, 2025-2035 (USD Million)
  2. 7.2.2 BY KEY PLAYERS BUSINESS MODEL, 2025-2035 (USD Million)
  3. 7.2.3 BY CHANNEL, 2025-2035 (USD Million)
  4. 7.2.4 BY TYPE OF SERVICE, 2025-2035 (USD Million)
  5. 7.2.5 BY APPLICATION, 2025-2035 (USD Million)
  6. 7.2.6 BY TARGET POPULATION SEGMENT, 2025-2035 (USD Million)
  7. 7.2.7 BY LEVEL OF SERVICE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

GCC Healthcare Market Segmentation

Healthcare By Counseling Approach (USD Million, 2025-2035)

Integrated
Independent
Discretionary Genetic Counseling

Healthcare By Key Players Business Model (USD Million, 2025-2035)

Core Genetic Counseling Companies
Direct-to-Consumer Genetic Testing Companies
Clinical Genetic Testing Companies

Healthcare By Channel (USD Million, 2025-2035)

Providers
Self-Referred Individuals

Healthcare By Type of Service (USD Million, 2025-2035)

Risk Assessment
Pharmacogenomics
Other Genetic Pediatric Care Counseling Services

Healthcare By Application (USD Million, 2025-2035)

Proactive Risk Assessment
GC For Intent-to-Treat Patients (ITT)
Prenatal and Preconception Care
Others

Healthcare By Target Population Segment (USD Million, 2025-2035)

General Population
Patient Population

Healthcare By Level of Service (USD Million, 2025-2035)

Pre-counseling Support
Post Counseling Support

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓